Skip to main content

Time to go for vivax

In 2002, the vivax malaria community has created a forum for providing a friendly environment to share and discuss research results on Plasmodium vivax. Meetings were held in Bangkok, Rockville, Panama, Barcelona, Bali, and, this year, in Manaus.

The aim of this Thematic series  ‘Time to go for vivax’ (the motto of the Manaus meeting) is to emphasize this biennial event and the role it plays in the promotion of work on Plasmodium vivax. The articles in the series are all based on presentations given in Manaus.

Guest editors: Marcus V Lacerda, FIOCRUZ, Brazil,  and Hernando A del Portillo, ISGlobal Barcelona, Spain.

  1. The relapsing nature of Plasmodium vivax infection is a major barrier to its control and elimination. Factors such as adequate dosing, adherence, drug quality, and pharmacogenetics can impact the effectiveness of...

    Authors: Anielle de Pina-Costa, Ana Carolina Rios Silvino, Edwiges Motta dos Santos, Renata Saraiva Pedro, José Moreira, Gabriela Liseth Umana, Ana Danielle Tavares da Silva, Otília Helena Lupi da Rosa Santos, Karina Medeiros de Deus Henriques, Cláudio Tadeu Daniel-Ribeiro, Patrícia Brasil, Tais Nobrega Sousa and André M. Siqueira
    Citation: Malaria Journal 2021 20:341
    Content type: Case report Published on:

  2. Automated detection of malaria and dengue infection has been actively researched for more than two decades. Although many improvements have been achieved, these solutions remain too expensive for most laborato...

    Authors: Parag Dharap and Sebastien Raimbault
    Citation: Malaria Journal 2020 19:429
    Content type: Methodology Published on:

  3. The Mindray BC-6800 haematology analyzer (BC-6800) provides a dedicated flag ‘Infected RBC’ (InR) and the number of InR (InR#)/the permillage of InR (InR‰) in routine blood testing as a screening tool for mala...

    Authors: Yi Sun, Daijun Xiang, Chen Chen, Shang He, Huan Qi and Chengbin Wang
    Citation: Malaria Journal 2019 18:262
    Content type: Methodology Published on:

  5. Plasmodium vivax remains an important cause of morbidity and mortality across the Americas, Horn of Africa, East and South East Asia. Control of transmission has been hampered by emergence of chloroquine resistan...

    Authors: Thomas C. S. Martin and Joseph M. Vinetz
    Citation: Malaria Journal 2018 17:89
    Content type: Opinion Published on:

  6. A distinctive feature of Plasmodium vivax infections is the overall low parasite density in peripheral blood. Thus, identifying asymptomatic infected individuals in endemic communities requires diagnostic tests w...

    Authors: Maria Gruenberg, Clara Antunes Moniz, Natalie Ellen Hofmann, Rahel Wampfler, Cristian Koepfli, Ivo Mueller, Wuelton Marcelo Monteiro, Marcus Lacerda, Gisely Cardoso de Melo, Andrea Kuehn, Andre M. Siqueira and Ingrid Felger
    Citation: Malaria Journal 2018 17:55
    Content type: Review Published on:

  7. The hypnozoite reservoir of Plasmodium vivax represents both the greatest obstacle and opportunity for ultimately eradicating this species. It is silent and cannot be diagnosed until it awakens and provokes a cli...

    Authors: J. Kevin Baird, Katherine E. Battle and Rosalind E. Howes
    Citation: Malaria Journal 2018 17:42
    Content type: Commentary Published on: